Literature DB >> 16644964

Monte Carlo simulation of a medical linear accelerator for radiotherapy use.

B Serrano1, A Hachem, E Franchisseur, J Hérault, S Marcié, A Costa, R J Bensadoun, J Barthe, J P Gérard.   

Abstract

A Monte Carlo code MCNPX (Monte Carlo N-particle) was used to model a 25 MV photon beam from a PRIMUS (KD2-Siemens) medical linear electron accelerator at the Centre Antoine Lacassagne in Nice. The entire geometry including the accelerator head and the water phantom was simulated to calculate the dose profile and the relative depth-dose distribution. The measurements were done using an ionisation chamber in water for different square field ranges. The first results show that the mean electron beam energy is not 19 MeV as mentioned by Siemens. The adjustment between the Monte Carlo calculated and measured data is obtained when the mean electron beam energy is approximately 15 MeV. These encouraging results will permit to check calculation data given by the treatment planning system, especially for small fields in high gradient heterogeneous zones, typical for intensity modulated radiation therapy technique.

Entities:  

Mesh:

Year:  2006        PMID: 16644964     DOI: 10.1093/rpd/nci620

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  3 in total

1.  Monte Carlo Calculation of the Energy Spectrum of a 6 MeV Electron Beam using PENetration and Energy Loss of Positrons and Electrons Code.

Authors:  Danny Giancarlo Apaza Veliz; Jorge Homero Wilches Visbal; Felipe Chen Abrego; José Luis Vega Ramírez
Journal:  J Med Phys       Date:  2020-07-20

Review 2.  Monte Carlo methods for device simulations in radiation therapy.

Authors:  Hyojun Park; Harald Paganetti; Jan Schuemann; Xun Jia; Chul Hee Min
Journal:  Phys Med Biol       Date:  2021-09-14       Impact factor: 4.174

3.  Monte-Carlo simulation of the Siemens Artiste linear accelerator flat 6 MV and flattening-filter-free 7 MV beam line.

Authors:  Alemeh Sadrollahi; Frank Nuesken; Norbert Licht; Christian Rübe; Yvonne Dzierma
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.